• Streptavidin-FITC for LNP Trafficking Assays

  2026-09-17

  Streptavidin-FITC converts biotinylated nanoparticles, nucleic acids, and antibodies into measurable fluorescent signals for microscopy and flow cytometry. Its strongest use in LNP research is not simply measuring uptake, but separating particle association, intracellular trafficking, and functional delivery across surface-charge and cell-state conditions.

• 5-Azacytidine Triggers ATR-Dependent DNA Damage

  2026-09-17

  The reference study shows that 5-azacytidine kills therapy-sensitive, therapy-resistant, and multidrug-resistant multiple myeloma cells through predominantly ATR-mediated DNA double-strand break responses and both caspase-dependent and caspase-independent apoptosis. Its synergy with doxorubicin and bortezomib provides a mechanistic preclinical rationale for combination strategies, although clinical translation requires validation beyond the cellular models examined.

• Self-Adaptive Nanocarriers for Pancreatic Cancer

  2026-09-16

  The ACS Nano study presents DATCPT, a pH/reactive oxygen species-responsive camptothecin nanocarrier designed to overcome circulation, stromal, penetration, and metastatic barriers in orthotopic pancreatic cancer. Its sequential charge adaptation, ROS-triggered matrix remodeling, and drug release provide a coordinated delivery strategy that is more mechanistically integrated than conventional passive nanocarriers.

• Adefovir: From HBV Polymerase to OAT1

  2026-09-16

  Adefovir and GS-0393 connect HBV polymerase inhibition with renal transporter biology. This article explains how to translate potency, exposure, formulation, and OAT1 kinetics into more interpretable hepatitis B virus research assays.

• RRP Restores Lipid Metabolism in Liver I/R Injury

  2026-09-15

  A 2024 Journal of Ethnopharmacology study found that Radix Rehmanniae Praeparata extracts reduced hepatic ischemia-reperfusion injury by rebalancing cholesterol synthesis and efflux. Its mechanistic contribution is the linkage of AMPK activation to suppression of the SCAP-SREBP2 axis and enhancement of LXRα-dependent cholesterol export in mouse and lipid-loaded hepatocyte models.

• Radiopathomics and Immunotherapy Response in Gastric Cancer

  2026-09-15

  A multicenter study developed an interpretable radiopathomics signature by combining baseline CT imaging with digital H&E pathology to predict response to immunotherapy-based combination therapy in gastric cancer. The signature achieved strong discrimination across training, internal validation, and external validation cohorts and also identified prognostic differences associated with immune regulation and memory B-cell infiltration.

• Dovitinib (TKI-258): ERK-to-Apoptosis Workflows

  2026-09-14

  Dovitinib (TKI-258) provides a practical way to perturb multiple RTK inputs while tracking ERK, STAT, viability, and apoptosis responses in cancer models. This workflow connects a melanoma signaling discovery to disciplined assay design for multiple myeloma research, hepatocellular carcinoma treatment research, and broader RTK-driven studies.

• Topotecan: From DNA Lesion to Assay Design

  2026-09-14

  Topotecan, also known as SKF104864, is more than a Topo I inhibitor: it is a schedule-dependent DNA damage probe. This guide connects its mechanism, recurrent SCLC evidence, and practical assay design for translational cancer research.

• Docosahexaenoic Acid (DHA) Research Workflows

  2026-09-13

  Build oxidation-conscious DHA experiments for membrane biology, neuroprotection research, inflammation, and retinal models. This guide connects practical dosing and assay design with an arachidonic-acid immune study while clearly separating evidence for DHA from hypothesis-generating extensions.

• Radiotherapy, PD-1/TIGIT Blockade, and CD8+ Memory

  2026-09-12

  The 2025 Cancer Letters study shows that radiotherapy combined with PD-1 and TIGIT blockade can produce local tumor control, abscopal responses, and durable immune memory in multiple mouse models. Its central mechanistic contribution is the identification of activated CD8+ T cells and M1 macrophage–T-cell communication as key components of this therapeutic synergy.

• Amplex Red for H2O2 and ROS Assays

  2026-09-11

  Amplex Red converts low-abundance hydrogen peroxide into a quantifiable resorufin fluorescence signal for enzyme, microsomal, mitochondrial, and cell-based workflows. Its most important optimization is matrix-aware control design, especially adding superoxide dismutase when NADPH or NADH is present.

• Streptavidin-Cy3 for Microrobot Assay Design

  2026-09-11

  Streptavidin-Cy3 provides a bright, biotin-specific readout for validating biohybrid microrobot localization, barrier penetration, and biomolecular payload distribution. This guide connects fluorescence assay design with the latest Euglena-based microrobot research while emphasizing controls, spectral planning, and workflow limitations.

• FK866 (APO866): Translational Logic for NAMPT

  2026-09-10

  A mechanistic and strategic guide to using FK866 (APO866) in NAD metabolism, hematologic cancer research, and translational assay design. The article connects NAMPT dependence, energy collapse, mitochondrial injury, and context-specific host biology while outlining practical validation priorities.

• Forskolin as a Precision cAMP Assay Tool

  2026-09-10

  Forskolin is a direct adenylate cyclase activator that can turn cAMP signaling into a controlled experimental variable. This article explains how to use it as a mechanistic assay anchor, including its relevance to trophoblast stress, ferroptosis, stem-cell models, and translational study design.

• 2',7'-Dichlorofluorescein diacetate for ROS Assays

  2026-09-09

  Use 2',7'-Dichlorofluorescein diacetate to quantify broad intracellular oxidative stress across microscopy, flow cytometry, and plate-based workflows. This guide also shows how to interpret the probe alongside redox-responsive nanocarrier studies without mistaking a general ROS signal for proof of one molecular species.

7798 records 1/520 page Next 12345 下5页 Last page